The Relationship Between Sarcopenia and the Systemic Immune‐Inflammation Index in a Patient Population Aged 80 and Above
International Journal of Clinical Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ijcp/6666417 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Practice, online erschienen am 23.06.2026. Verfasst von Handan Duman und 1 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Recep Tayyip Erdogan Üniversitesi.
Abstract (Originalsprache)
Background
As the older adult population continues to grow rapidly worldwide, health issues related to aging have become increasingly important in recent years. Sarcopenia, defined as the loss of muscle mass and function associated with aging, significantly impacts the quality of life of older adults.
Objective
This study investigated the relationship between the risk of sarcopenia and the Systemic Immune‐Inflammation Index (SII) in older adults aged ≥ 80 years.
Methods
This study involved 214 patients aged ≥ 80 years who presented to the Rize Recep Tayyip Erdoğan University Training and Research Hospital. The risk of sarcopenia was assessed using the Strength, Assistance with Walking, Rising from a Chair, Climbing Stairs, and Falls questionnaire, and laboratory tests were performed to analyze inflammation levels.
Results
The study revealed significant differences in inflammation parameters among patients at risk of sarcopenia. SII and C‐reactive protein/albumin ratio were particularly associated with sarcopenia risk. Age, sex, albumin level, neutrophil count, platelet count, and SII were independent predictors of sarcopenia risk. Receiver operating characteristic analysis showed that the SII was associated with SARC‐F‐defined sarcopenia risk although its discriminative performance was modest.
Conclusion
Our findings support a link between systemic inflammation and SARC‐F‐defined sarcopenia risk in very old adults. Although the discriminative performance of the SII was modest, it may serve as a complementary biomarker in the multidimensional assessment of sarcopenia risk.
Förderung
- Recep Tayyip Erdogan Üniversitesi
Zitieren
APA
Duman, H., & Tüfekçi, D. (2026). The Relationship Between Sarcopenia and the Systemic Immune‐Inflammation Index in a Patient Population Aged 80 and Above. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/6666417
Vancouver
Duman H, Tüfekçi D. The Relationship Between Sarcopenia and the Systemic Immune‐Inflammation Index in a Patient Population Aged 80 and Above. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/6666417
BibTeX
@article{Duman2026,
author = {Duman, Handan and Tüfekçi, Damla},
title = {The Relationship Between Sarcopenia and the Systemic Immune‐Inflammation Index in a Patient Population Aged 80 and Above},
journal = {International Journal of Clinical Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijcp/6666417}
}
EUVIMED